Fidelity Investments’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-450
Closed -$1.08K 5580
2025
Q4
$1.08K Buy
450
+140
+45% +$345 ﹤0.01% 5087
2025
Q3
$825 Sell
310
-1,636
-84% -$4.84K ﹤0.01% 5041
2025
Q2
$5.78K Buy
1,946
+1,000
+106% +$2.91K ﹤0.01% 4680
2025
Q1
$3.06K Sell
946
-31,547
-97% -$109K ﹤0.01% 4815
2024
Q4
$128K Buy
32,493
+3,501
+12% +$23.9K ﹤0.01% 3444
2024
Q3
$224K Buy
28,992
+7,420
+34% +$48.7K ﹤0.01% 3159
2024
Q2
$111K Buy
21,572
+1,606
+8% +$12.4K ﹤0.01% 3257
2024
Q1
$162K Sell
19,966
-74
-0.4% -$424 ﹤0.01% 3101
2023
Q4
$80.2K Hold
20,040
﹤0.01% 3302
2023
Q3
$82.6K Hold
20,040
﹤0.01% 3164
2023
Q2
$119K Sell
20,040
-400
-2% -$1.8K ﹤0.01% 3108
2023
Q1
$70.5K Buy
20,440
+160
+0.8% +$596 ﹤0.01% 3313
2022
Q4
$71.2K Hold
20,280
﹤0.01% 3325
2022
Q3
$73K Sell
20,280
-1,017
-5% -$4.79K ﹤0.01% 3356
2022
Q2
$120K Buy
21,297
+772
+4% +$5.19K ﹤0.01% 3266
2022
Q1
$177K Buy
+20,525
New +$206K ﹤0.01% 3284
2021
Q2
Sell
-125
Closed -$2K 4957
2021
Q1
$2K Hold
125
﹤0.01% 3761
2020
Q4
$2K Buy
+125
New +$2.3K ﹤0.01% 3628
2020
Q3
Sell
-135
Closed -$2K 4042
2020
Q2
$2K Buy
+135
New +$1.9K ﹤0.01% 3407

Other funds holding XBIT

Fidelity Investments's XBIT Position: Q1 2026 in Review

Fidelity Investments sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 450 shares — an estimated $1.08K sold.

Fidelity Investments first reported a position in XBIT in Q2 2020 and held it in 19 quarters. The position peaked at $224K in Q3 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Fidelity Investments reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 450 XBiotech shares in Q1 2026, an estimated $1.08K.
  • Fidelity Investments first reported a position in XBiotech in Q2 2020 and held it in 19 quarters.
  • Fidelity Investments's XBiotech position peaked at $224K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.